SHIRLEY GRIFFITH: FDA officials say the safety of Truvada was confirmed in two large studies. One study involved more than four thousand seven hundred heterosexual couples. In these relationships, one person was infected with HIV; their partner was not. Tests showed that Truvada reduced the risk of becoming infected by seventy-five percent when compared with a pill to a placebo or harmless substance.
Kali Lindsey of the National Minority AIDS Council says the drug could have a major effect.
KALI LINDSEY: “Using Truvada -- or pre-exposure prophylaxis -- to prevent acquiring HIV for an HIV negative person is a game-changer, and it’s something that I believe is going to really take us to the next level.”
Gottfried Hirnchall is the director of the HIV/AIDS program at the World Health Organization in Switzerland. He spoke to VOA on Skype.
DR. GOTTFRIED HIRNCHALL: “We have to really see how this could best be done and which would be the populations or the individuals where this would pay off.”
Dr. Hirnchall says intervention with Truvada is not for everyone.
DR. GOTTFRIED HIRNCHALL: “Let’s remember, once you start on pre-exposure prophylaxis you cannot just take it some days and not on other days. So we will really have to provide the support to people to take this every single day of their life. And let us also not forget we have many other prevention methods now available that we can use.”
最新
2013-11-25
2013-11-25
2013-11-25
2013-11-25
2013-11-25
2013-11-25